Cresco Labs Stock-Based Compensation Growth & History (CRLBF)
Cresco Labs's stock-based compensation was $11.2M for fiscal 2025.
View full Cresco Labs company overviewCresco Labs annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $11.2M | −$2.9M | −20.69% |
| 2024 | 2024-12-31 | $14.2M | −$2.2M | −13.40% |
| 2023 | 2023-12-31 | $16.4M | $6.3M | +63.38% |
| 2022 | 2022-12-31 | $10.0M | $5.4M | +119.40% |
| 2021 | 2021-12-31 | $4.6M | −$12.1M | −72.61% |
| 2020 | 2020-12-31 | $16.7M | $2.6M | +18.60% |
| 2019 | 2019-12-31 | $14.0M | — | — |
Cresco Labs quarterly stock-based compensation
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.8M | $1.2M | +48.19% |
| Q1 2026 | 2026-03-31 | $5.3M | — | — |
| Q4 2025 | 2025-12-31 | $3.7M | — | — |
| Q3 2025 | 2025-09-30 | $2.3M | — | — |
| Q2 2025 | 2025-06-30 | $2.5M | — | — |
Cresco Labs stock-based compensation trends
Over the last five fiscal years, Cresco Labs's stock-based compensation decreased from $16.7M to $11.2M, a change of −$5.4M. The latest reported quarter, Q2 2026, shows $3.8M.
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cresco Labs source filings ↗